Logo
C

CeleScreen

10 employees

CeleScreen develops an innovative technology for the rapid screening of xenobiotics toxicity.

Basic info

Industry

personal care product manufacturing

Sectors

drug design
reprotoxicity
Cosmetics
C. elegans
lead optimization
REACH
toxicology
teratogenicity
systemic toxicity

Date founded

2015

Funding rounds raised

C

CeleScreen raised undisclosed on July 1, 2014

Investors: Agoranov

FAQ